O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-1.08%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.88B
AUM Growth
+$7.88B
(-24%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-25.25%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
148
New
11
Increased
16
Reduced
57
Closed
17
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$106M |
| 2 |
Amicus Therapeutics
FOLD
|
$80.2M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$77.8M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$43.5M |
| 5 |
scPharmaceuticals
SCPH
|
$41.2M |
Top Sells
| 1 |
Incyte
INCY
|
$172M |
| 2 |
AET
Aetna Inc
AET
|
$171M |
| 3 |
Biogen
BIIB
|
$127M |
| 4 |
Merck
MRK
|
$105M |
| 5 |
Gilead Sciences
GILD
|
$101M |
Sector Composition
| 1 | Healthcare | 91.38% |
| 2 | Financials | 1.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$19.4B
| $392M | 4.96% | 1,230,700 -399,300 | -24% | -$127M |
|
|
ALXN
2
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $344M | 4.36% | 2,879,575 -765,911 | -21% | -$91.6M |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $321M | 4.06% | 854,600 +281,830 | +49% | +$106M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $320M | 4.04% | 3,062,850 -289,127 | -9% | -$30.2M |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $261M | 3.3% | 1,741,300 -333,002 | -16% | -$49.9M |
|
6
Boston Scientific
BSX
$156B
| $257M | 3.26% | 10,386,600 -3,010,400 | -22% | -$74.6M |
|
7
Amgen
AMGN
$155B
| $226M | 2.85% | 1,297,100 +44,000 | +4% | +$7.65M |
|
8
Puma Biotechnology
PBYI
$254M
| $216M | 2.73% | 2,184,535 -241,200 | -10% | -$23.8M |
|
|
9
Merck
MRK
$210B
| $204M | 2.58% | 3,625,400 -1,861,600 | -34% | -$105M |
|
|
CMTA
10
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $198M | 2.5% | 10,425,225 | – | – |
|
11
Cigna
CI
$80.3B
| $197M | 2.49% | 969,300 -296,800 | -23% | -$60.3M |
|
12
Eli Lilly
LLY
$657B
| $193M | 2.44% | 2,288,000 -787,000 | -26% | -$66.5M |
|
13
Agilent Technologies
A
$35.7B
| $173M | 2.19% | 2,590,700 -1,048,200 | -29% | -$70.2M |
|
|
WMGI
14
DELISTED
Wright Medical Group Inc
WMGI
| $152M | 1.92% | 6,852,068 -2,094,166 | -23% | -$46.5M |
|
15
Elevance Health
ELV
$71.8B
| $148M | 1.87% | 658,718 -268,900 | -29% | -$60.5M |
|
|
IMMU
16
DELISTED
Immunomedics Inc
IMMU
| $137M | 1.73% | 8,461,727 -1,535,089 | -15% | -$24.8M |
|
17
Ascendis Pharma
ASND
$11.8B
| $135M | 1.71% | 3,367,315 | – | – |
|
|
CLVS
18
DELISTED
Clovis Oncology, Inc.
CLVS
| $134M | 1.7% | 1,971,670 -417,000 | -17% | -$28.4M |
|
|
BOLD
19
DELISTED
Audentes Therapeutics, Inc
BOLD
| $129M | 1.63% | 4,129,638 | – | – |
|
20
Edwards Lifesciences
EW
$47.8B
| $127M | 1.6% | 1,124,100 -266,600 | -19% | -$30M |
|
21
Alnylam Pharmaceuticals
ALNY
$58.5B
| $120M | 1.51% | 941,600 -143,200 | -13% | -$18.2M |
|
|
ONC
22
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $102M | 1.29% | 1,041,488 -272,300 | -21% | -$26.6M |
|
23
AbbVie
ABBV
$372B
| $102M | 1.29% | 1,050,600 -914,400 | -47% | -$88.4M |
|
|
ARRY
24
DELISTED
Array Biopharma Inc
ARRY
| $97.6M | 1.23% | 7,621,400 -6,561,500 | -46% | -$84M |
|
25
Select Medical
SEM
$1.61B
| $89.6M | 1.13% | 5,074,200 -504,300 | -9% | -$8.9M |
|